BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10403910)

  • 1. Analysis of human C4A and C4B binding to an immune complex in serum.
    Reilly BD
    Clin Exp Immunol; 1999 Jul; 117(1):12-8. PubMed ID: 10403910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitation.
    Gatenby PA; Barbosa JE; Lachmann PJ
    Clin Exp Immunol; 1990 Feb; 79(2):158-63. PubMed ID: 2138067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular deposition of the complement C4 isotypes C4A and C4B in glomeruonephritis.
    Lhotta K; Schlogl A; Kronenberg F; Joannidis M; Konig P
    Nephrol Dial Transplant; 1996 Jun; 11(6):1024-8. PubMed ID: 8671963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent binding properties of the human complement protein C4 and hydrolysis rate of the internal thioester upon activation.
    Sepp A; Dodds AW; Anderson MJ; Campbell RD; Willis AC; Law SK
    Protein Sci; 1993 May; 2(5):706-16. PubMed ID: 8495193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of C4Ab and C4Bb binding to the C3b/C4b receptor (CR1, CD35).
    Reilly BD; Mold C
    Clin Exp Immunol; 1997 Nov; 110(2):310-6. PubMed ID: 9367418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative roles of C4A and C4B in prevention of immune precipitation, solubilisation and immune adherence.
    Holme ER; Veitch J; Johnston A; McKay IC; Whaley K
    Rheumatol Int; 1992; 12(5):187-90. PubMed ID: 1290020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C4A and C4B isotypic forms of human complement fragment C4b have the same intrinsic affinity for complement receptor 1 (CR1/CD35).
    Clemenza L; Isenman DE
    J Immunol; 2004 Feb; 172(3):1670-80. PubMed ID: 14734749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalently-bound human C4b dimers consisting of C4B isotype show higher hemolytic activity than those of C4A in the C3-bypass complement pathway.
    Masaki T; Matsumoto M; Hara T; Nakanishi I; Kitamura H; Seya T
    Mol Immunol; 1995 Jan; 32(1):21-6. PubMed ID: 7870055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in the biological properties of the two forms of the fourth component of human complement (C4).
    Schifferli JA; Steiger G; Paccaud JP; Sjöholm AG; Hauptmann G
    Clin Exp Immunol; 1986 Feb; 63(2):473-7. PubMed ID: 3486068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-mediated adherence of immune complexes to human erythrocytes. Difference in the requirements for C4A and C4B.
    Schifferli JA; Hauptmann G; Paccaud JP
    FEBS Lett; 1987 Mar; 213(2):415-8. PubMed ID: 3493921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two isotypes of human C4, C4A and C4B have different structure and function.
    Schifferli JA; Paccaud JP
    Complement Inflamm; 1989; 6(1):19-26. PubMed ID: 2650988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of soluble human complement receptor type 1 (sCR1, BRL55730) with human complement component C4.
    Gibb AL; Freeman AM; Smith RA; Edmonds S; Sim E
    Biochim Biophys Acta; 1993 Jan; 1180(3):313-20. PubMed ID: 8422437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement C4A Regulates Autoreactive B Cells in Murine Lupus.
    Simoni L; Presumey J; van der Poel CE; Castrillon C; Chang SE; Utz PJ; Carroll MC
    Cell Rep; 2020 Nov; 33(5):108330. PubMed ID: 33147456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of thiol compounds on human complement component C4.
    Edmonds S; Gibb A; Sim E
    Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):801-5. PubMed ID: 8435078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index.
    Yang Y; Chung EK; Zhou B; Blanchong CA; Yu CY; Füst G; Kovács M; Vatay A; Szalai C; Karádi I; Varga L
    J Immunol; 2003 Sep; 171(5):2734-45. PubMed ID: 12928427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.
    Zorzetto M; Datturi F; Divizia L; Pistono C; Campo I; De Silvestri A; Cuccia M; Ricevuti G
    Curr Alzheimer Res; 2017; 14(3):303-308. PubMed ID: 27758680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent binding properties of the C4A and C4B isotypes of the fourth component of human complement on several C1-bearing cell surfaces.
    Isenman DE; Young JR
    J Immunol; 1986 Apr; 136(7):2542-50. PubMed ID: 3512717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between copy number of genes (C4A, C4B) encoding the fourth component of complement and the clinical course of hereditary angioedema (HAE).
    Blaskó B; Széplaki G; Varga L; Ronai Z; Prohászka Z; Sasvari-Szekely M; Visy B; Farkas H; Füst G
    Mol Immunol; 2007 Apr; 44(10):2667-74. PubMed ID: 17229465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.
    Ebanks RO; Jaikaran AS; Carroll MC; Anderson MJ; Campbell RD; Isenman DE
    J Immunol; 1992 May; 148(9):2803-11. PubMed ID: 1573269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydralazine binds covalently to complement component C4. Different reactivity of C4A and C4B gene products.
    Sim E; Law SK
    FEBS Lett; 1985 May; 184(2):323-7. PubMed ID: 3873356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.